| Desonide Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Desonide 0.05% | ointment | topical | 100.0 gram(s) | OTC |
| Desonide 0.05% | lotion | topical | 100.0 milliliter(s) | OTC |
| Desonide 0.05% | cream | topical | 100.0 gram(s) | OTC |
| Desonide - | powder | compounding | 100.0 gram(s) | OTC |
SkinMedica Introduces Desonate(R) (desonide) Gel 0.05% TwinPack ... - FOX News
Formulated with desonide, the leading low-potency corticosteroid used in dermatology, Desonate is the first and only treatment for atopic dermatitis ...
Tue Jan 08 05:07:23 -0500 2008
DUSA Expands Global Sales With Launch of Levulan(R) Kerastick(R ... - CNNMoney.com
... Verdeso(TM) (desonide) Foam, 0.05%; Brevoxyl® Creamy Wash (benzoyl peroxide, 4% or 8%) packaged in the convenient new Brevoxyl Acne Wash Kit; Oilatum®; ...
Mon Oct 01 03:38:02 -0400 2007
Mikus et lobes are unknown and arti. - AutoWeb.sk
Properties and are beneficial confirmed by desonide multiple cities reaction. These factors infections in share electron approach. Types of doctor shortage ...
Sun Jul 01 10:58:44 -0400 2007
desonide - A synthetic glucocorticosteroid for topical use, with anti-inflammatory activity. Desonide binds to glucocorticoid receptors in the cytoplasm, and the ligand-receptor complex is translocated as a homodimer into the nucleus, where transcription activation via glucocorticoid response elements within glucocorticoid-responsive genes occur. This agent induces transcription of genes coding for anti-inflammatory proteins, including lipocortin-1, interleukin-10, interleukin-1 receptor antagonist and neutral endopeptidase. Increased synthesis of lipocortin-1 has an inhibitory effect on phospholipase A2, which in turn inhibits the release arachidonic acid, thereby controlling the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes.